Polycyclic N-benzamido imides with potent activity against vaccinia virus

16Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The synthesis and antiviral activity of a series of novel polycyclic analogues of the orthopoxvirus egress inhibitor tecovirimat (ST-246) is presented. Several of these compounds display submicromolar activity against vaccinia virus, and were more potent than cidofovir (CDV). The more active compounds were about 10-fold more active than CDV, with minimum cytotoxic concentrations above 100 μ. Chemical manipulations of the two carbon-carbon double bonds present in the compounds were carried out to further explore the structure-activity relationships of these new polycyclic imides. Hydrogenation of the two carbon-carbon double bonds decreases antiviral activity, whereas either cyclopropanation or epoxidation of the double bonds fully eliminates the antiviral activity. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Torres, E., Duque, M. D., Camps, P., Naesens, L., Calvet, T., Font-Bardia, M., & Vázquez, S. (2010). Polycyclic N-benzamido imides with potent activity against vaccinia virus. ChemMedChem, 5(12), 2072–2078. https://doi.org/10.1002/cmdc.201000306

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free